Posts on topic biomarkers

Industry News: Precision Medicine in Study and Practice for Detecting Lung Cancer

August 8, 2019 by CHEST Market Growth Team

When will clinicians feel comfortable using emerging technologies including genomic tests to detect lung cancer? The topic is addressed in the recently released CHEST Clinical PerspectivesTM white paper “Precision Medicine: Adoption of Emerging Methods of Evaluation and Therapy,” which examines personalized medicine adoption, including the testing of biomarkers [Read more...]

Category: Clinical Perspectives

Related Topics: biomarkers, Lung Cancer, Precision Medicine


CHEST Clinical Perspectives™ Explores the Emerging Field of Precision Medicine

July 17, 2019 by CHEST Market Growth Team

For clinicians seeking to provide a unique way to treat or diagnose a patient, a recent study found that the issues go beyond awareness or patients feeling comfortable—there remains the question of something as simple as: what should we call it?  Clinicians remain uncertain whether to name the [Read more...]

Category: Clinical Perspectives

Related Topics: biomarkers, Personalized Medicine, Precision Medicine